Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1996
10/22/1996US5567804 Human leucocyte elastase inhibitor; antioxidant
10/22/1996US5567733 Mucous membrane
10/22/1996US5567721 Aromatic urea compound for skin disorder, rheumatic disease, respiratory disorder and eye disorder
10/22/1996US5567683 Antiinflammatory agents
10/22/1996US5567597 Hydrolytic enzyme inhibitors/inactivators and methods for using same
10/22/1996US5567437 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation
10/22/1996US5567409 Administering a tetrapyrrole carboxylic acid in sufficient quantity to accumulate in arthritic lesion; applying light to cause it to produce fluorescence
10/22/1996CA2007655C Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996CA2217817A1 Lactacystin analogs
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
10/16/1996EP0737195A1 New ginkgolide derivatives and a process for preparing them
10/16/1996EP0737194A1 Diazabicyclic neurokinin antagonists
10/16/1996EP0737192A1 Substituted morpholine derivatives and their use as therapeutic agents
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737068A1 2,3-diaryl-1-benzopyrans for treating dermatitis
10/16/1996EP0540673B1 Acetylene derivatives having lipoxygenase inhibitory activity
10/16/1996CN1133288A Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof
10/16/1996CN1133287A Inhibitor for squalene synthetic enzyme
10/16/1996CN1033029C Prepn. of indenoindole compound
10/15/1996US5565613 2-arylpropionic acid preparations and process for their production
10/15/1996US5565561 Natural substance cyclamenol and chemical derivatives
10/15/1996US5565560 Treating autoimmune diseases, preventing transplant rejection
10/15/1996US5565491 Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
10/15/1996US5565488 Oxalylamino-benzofuran- and benzothienyl-derivatives
10/15/1996US5565452 9-amino-pyridazino[4',5':3,4]pyrrolo-[2,1-A]isoquinolines and the use thereof for the production of pharmaceutical preparations
10/15/1996US5565448 Antiinflammatory agent, cardiovascular disorders, septic shock
10/15/1996US5565446 Useful in treatment of inflammatory diseases
10/15/1996US5565441 Phosphonoacetic esters and acids as anti-inflammatories
10/15/1996US5565440 Antiinflammatory, antipyritic, analgesic, antirheumatic, antiarthritic or antiosteoprosis agent
10/15/1996US5565433 Administering in treatment and prevention of inflammatory diseases
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996US5565429 Human leucocyte elastase inhibitors; emphysema; antiarthritic agents; rheumatic diseases
10/10/1996WO1996031529A1 Peptides and remedy for autoimmune diseases comprising the same
10/10/1996WO1996031514A1 Ascomycins
10/10/1996WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/10/1996WO1996031509A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES
10/10/1996WO1996031499A1 Novel heterocyclic compounds
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996WO1996031497A1 Novel heterocyclic compounds
10/10/1996WO1996031492A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996WO1996031487A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
10/10/1996WO1996031486A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
10/10/1996WO1996031485A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
10/10/1996WO1996031481A1 Novel heterocyclic compounds
10/10/1996WO1996031474A1 Novel heterocyclic compounds
10/10/1996WO1996031471A1 Novel method
10/10/1996WO1996031468A1 Novel heterocyclic compounds
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996CA2217206A1 Novel heterocyclic compounds
10/10/1996CA2217202A1 Novel heterocyclic compounds
10/10/1996CA2217200A1 Novel method
10/10/1996CA2217198A1 Novel heterocyclic compounds
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/10/1996CA2217194A1 Novel heterocyclic compounds
10/10/1996CA2217130A1 Novel heterocyclic compounds
10/10/1996CA2216809A1 Imidazo[1,2-a]pyridine derivatives
10/10/1996CA2216562A1 Ascomycins
10/10/1996CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736036A1 Kininogen inhibitors
10/09/1996EP0736016A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
10/09/1996EP0736012A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
10/09/1996EP0736011A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
10/09/1996EP0736007A1 Non-peptide tachykinin receptor antagonists
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0735880A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
10/09/1996EP0735872A1 A method of treating neurogenic inflammation
10/09/1996EP0735821A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0609415B1 Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation
10/09/1996EP0594578B1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
10/09/1996CN1133048A Oligopeptides derived from C-reactive protein fragments
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133045A 7-azabicyclo-|2,2,1¨-heptane and-heptene derivatives as analgesics and anti-inflammatory agents
10/09/1996CN1133006A Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple
10/09/1996CN1133004A Process for conditioning substances
10/09/1996CN1132755A Aescinic lactonic derivative, its prep. and medicine composition thereof
10/09/1996CN1132607A Fortified fruit juices
10/08/1996US5563268 Heterobiaryl derivatives
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/03/1996WO1996030397A1 New peptides with immunomodulatory effects
10/03/1996WO1996030377A1 Nitrogenous macrocyclic compounds
10/03/1996WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030042A2 Methods of treating inflammation and compositions therefor
10/03/1996WO1996030021A1 Azathioprine compositions for colonic administration
10/03/1996WO1996030016A2 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996029987A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 1272